Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
14.00
-3.80 (-21.35%)
At close: Jul 22, 2025

Elevation Oncology Statistics

Total Valuation

TEVJF has a market cap or net worth of 18.69 billion. The enterprise value is 34.08 billion.

Market Cap18.69B
Enterprise Value 34.08B

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date Jul 30, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 1.15B
Shares Outstanding n/a
Shares Change (YoY) +1.25%
Shares Change (QoQ) +0.17%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.14B

Valuation Ratios

PE Ratio n/a
Forward PE 6.29
PS Ratio 1.12
PB Ratio 2.73
P/TBV Ratio n/a
P/FCF Ratio 21.00
P/OCF Ratio 13.44
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.30, with an EV/FCF ratio of 38.29.

EV / Earnings -217.04
EV / Sales 2.05
EV / EBITDA 7.30
EV / EBIT 9.72
EV / FCF 38.29

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 2.57.

Current Ratio 1.06
Quick Ratio 0.48
Debt / Equity 2.57
Debt / EBITDA 3.76
Debt / FCF 19.71
Interest Coverage 3.59

Financial Efficiency

Return on equity (ROE) is -2.42% and return on invested capital (ROIC) is 8.77%.

Return on Equity (ROE) -2.42%
Return on Assets (ROA) 5.37%
Return on Invested Capital (ROIC) 8.77%
Return on Capital Employed (ROCE) 12.38%
Revenue Per Employee 449,405
Profits Per Employee -4,243
Employee Count35,686
Asset Turnover 0.41
Inventory Turnover 2.26

Taxes

In the past 12 months, TEVJF has paid 94.00 million in taxes.

Income Tax 94.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -18.56% in the last 52 weeks. The beta is 0.62, so TEVJF's price volatility has been lower than the market average.

Beta (5Y) 0.62
52-Week Price Change -18.56%
50-Day Moving Average 17.01
200-Day Moving Average 11.33
Relative Strength Index (RSI) 43.31
Average Volume (20 Days) 504

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.51

Income Statement

In the last 12 months, TEVJF had revenue of 16.63 billion and -157.00 million in losses. Loss per share was -0.14.

Revenue16.63B
Gross Profit 8.25B
Operating Income 3.50B
Pretax Income -68.00M
Net Income -157.00M
EBITDA 4.52B
EBIT 3.50B
Loss Per Share -0.14
Full Income Statement

Balance Sheet

The company has 2.16 billion in cash and 17.54 billion in debt, giving a net cash position of -15.38 billion.

Cash & Cash Equivalents 2.16B
Total Debt 17.54B
Net Cash -15.38B
Net Cash Per Share n/a
Equity (Book Value) 6.83B
Book Value Per Share 5.95
Working Capital 759.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.39 billion and capital expenditures -500.00 million, giving a free cash flow of 890.00 million.

Operating Cash Flow 1.39B
Capital Expenditures -500.00M
Free Cash Flow 890.00M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 49.60%, with operating and profit margins of 21.05% and -0.94%.

Gross Margin 49.60%
Operating Margin 21.05%
Pretax Margin -0.41%
Profit Margin -0.94%
EBITDA Margin 27.20%
EBIT Margin 21.05%
FCF Margin 5.35%

Dividends & Yields

TEVJF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.25%
Shareholder Yield n/a
Earnings Yield -0.84%
FCF Yield 4.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TEVJF has an Altman Z-Score of 0.57 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.57
Piotroski F-Score 6